NAD+ and Mitochondrial Peptides Explained: MOTS-c, Humanin & SS-31

Mitochondria are the energy-producing organelles in every cell. They convert nutrients into ATP (adenosine triphosphate) — the universal energy currency of the body. As we age, mitochondrial function declines:

• •ATP production drops by approximately 8% per decade after age 30
• •Mitochondrial DNA mutations accumulate over time
• •Reactive oxygen species (ROS) increase, causing oxidative damage
• •Mitochondrial biogenesis (creation of new mitochondria) slows
• •NAD+ levels decline by approximately 50% between ages 40 and 60

This mitochondrial decline is now considered a primary hallmark of ageing — not just a consequence of it. The decline in cellular energy affects every organ system: the brain, heart, muscles, immune system, and skin all suffer when mitochondria underperform.

This has led to intense research interest in compounds that can restore mitochondrial function — including NAD+ precursors and mitochondrial-derived peptides (MDPs).

What Is NAD+? Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in every living cell. It's essential for: - Energy metabolism: Required for glycolysis, the TCA cycle, and oxidative phosphorylation - DNA repair: Substrate for PARP enzymes that fix DNA damage - Sirtuin activation: NAD+ is the required co-substrate for sirtuins (SIRT1-7), which regulate ageing, inflammation, and metabolism - Cellular signalling: Involved in calcium signalling and immune function

Why NAD+ Declines With Age: 1. Increased consumption by CD38 (an enzyme that rises with inflammation) 2. Increased PARP activity (more DNA damage to repair) 3. Decreased synthesis from precursors 4. Reduced recycling through salvage pathways

NAD+ Precursors: Since NAD+ itself has poor oral bioavailability, research focuses on precursors: - NMN (Nicotinamide Mononucleotide): Direct NAD+ precursor, one enzymatic step away - NR (Nicotinamide Riboside): Converted to NMN, then to NAD+ - Niacin/Niacinamide: Older precursors with established but more modest effects - IV NAD+: Direct infusion, bypassing oral absorption issues

Research Status: - Human trials with NMN and NR show successful NAD+ elevation - Whether NAD+ restoration translates to clinical anti-ageing benefits is still being established - The CALERIE and other longevity trials are providing important data

MDPs are a recently discovered class of peptides encoded within the mitochondrial genome. Unlike nuclear-encoded peptides, these are produced directly by mitochondria and appear to function as retrograde signals — mitochondria communicating their status to the rest of the cell and body.

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c): - 16 amino acid peptide encoded in the mitochondrial 12S rRNA gene - Discovered by Changhan David Lee's lab at USC in 2015 - Functions as a "mitokine" — a mitochondrial-derived hormone - Key Effects: - Activates AMPK (the cellular energy sensor) - Improves insulin sensitivity - Enhances exercise capacity in animal models - Promotes fatty acid oxidation - May protect against age-related metabolic decline - Research Status: Preclinical studies show remarkable metabolic effects. Early human data is emerging. The peptide is currently in research use only.

Humanin: - 24 amino acid peptide encoded in the mitochondrial 16S rRNA gene - Discovered in 2001 in Alzheimer's disease research - Functions as a cytoprotective signal - Key Effects: - Anti-apoptotic (prevents programmed cell death) - Neuroprotective against amyloid-beta toxicity - Improves insulin sensitivity via IGFBP-3 interaction - Cardioprotective in ischaemia models - Levels decline with age in humans - Research Status: Multiple preclinical studies support cytoprotective role. Endogenous humanin levels are being studied as ageing biomarkers.

SS-31 (Elamipretide / Bendavia): - Synthetic tetrapeptide (D-Arg-Dmt-Lys-Phe-NH₂) - Not mitochondrial-derived but mitochondria-targeted - Concentrates >1000-fold in mitochondria via cardiolipin binding - Key Effects: - Stabilises cardiolipin in the inner mitochondrial membrane - Restores electron transport chain efficiency - Reduces ROS production - Improves ATP synthesis - Protects against ischaemia-reperfusion injury - Research Status: Phase II/III clinical trials for Barth syndrome, heart failure, and age-related mitochondrial dysfunction. Most clinically advanced mitochondrial peptide.

The emerging picture in longevity research suggests that targeting mitochondrial health from multiple angles may be more effective than any single intervention:

Theoretical Multi-Target Approach: 1. NAD+ restoration (NMN or NR) → provides the raw coenzyme for energy production 2. MOTS-c → activates AMPK, improves metabolic efficiency 3. SS-31 → stabilises mitochondrial membrane structure, reduces ROS 4. Humanin → cytoprotection, prevents mitochondrial-mediated apoptosis

Supporting Lifestyle Factors: Research consistently shows that lifestyle interventions are the most validated approaches to mitochondrial health: - Exercise: The most potent mitochondrial biogenesis stimulus. Resistance and aerobic exercise both enhance mitochondrial function - Cold exposure: May activate mitochondrial uncoupling proteins - Caloric restriction/fasting: Activates sirtuins and AMPK via NAD+ elevation - Sleep: Mitochondrial repair and quality control occur during sleep

What We Don't Know: - Optimal dosing for MDPs in humans - Long-term safety of sustained AMPK activation - Whether exogenous MOTS-c replicates the effects of endogenous production - Whether combining multiple mitochondrial interventions produces additive or diminishing returns - The role of individual genetic variation in MDP response

The Current Evidence Level: Most mitochondrial peptide research is preclinical. SS-31 is the furthest along in clinical development. NAD+ precursors (NMN, NR) have the most human data but still lack definitive longevity outcome studies.

Disclaimer: This article is for educational purposes only. Mitochondrial peptides are research compounds not approved for human anti-ageing use. NAD+ precursors are available as supplements but therapeutic claims are not approved. Consult healthcare professionals for personalised advice.